STAT3 and cancer: The aberrant activation of STAT proteins, most particularly STAT1, STAT3 and STAT5, has been suspected or proposed to significantly contribute to the progression of a variety of human tumors and cancer cell lines, including hematologic malignancies and solid tumors (reviewed in [23]).